Sumitomo Dainippon Pharma Co. Ltd., of Osaka, Japan, appointed Hiroshi Noda senior director, regulatory compliance and quality assurance management, Izuru Miyawaki senior director, preclinical research unit and director, toxicology group I, preclinical research unit, and Hiroyuki Nishii senior director, Ibaraki and Ehime plants; each appointment effective Oct. 1.